MeSH tree: C10.551
New research from Peter Mac has uncovered why some parts of the brain may be more vulnerable to tumor growth than others, offering new clues into how brain cancers begin and how they could one day be stopped. Published in ...
May 21, 2026
0
4
Each year, approximately 2,000 people aged 18–39 are diagnosed with cancer in Sweden. Most survive their illness, but for many, life continues with long-term consequences. In a new doctoral dissertation, Charlotta Bergström ...
May 19, 2026
0
3
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity-related ...
May 14, 2026
0
4
Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the human brain and providing a deeper understanding of how the aggressive brain cancer works.
May 13, 2026
0
4
New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan.
May 6, 2026
0
22
Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...
May 4, 2026
0
14
Scientists at St. Jude Children's Research Hospital today report how lifesaving childhood cancer treatments leave "fingerprints" on DNA, which can lead to second neoplasms (cancers or cancer-like diseases) decades later. ...
Apr 20, 2026
0
4
Researchers at the University of Sussex, in collaboration with scientists from different institutes worldwide, have identified a blood test capable of early diagnosis of the most aggressive form of brain tumor. The technology ...
Apr 20, 2026
0
9
A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care and the latest advances ...
Apr 17, 2026
0
6
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant non-small cell lung cancer (NSCLC), providing a safe and effective oral targeted treatment alternative to ...
Apr 16, 2026
0
6
